L M Slater

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16
    Lewis M Slater
    Division of Hematology Oncology, Department of Medicine, University of California Irvine, Med Surge II Room 375B, Irvine, CA 92697 1875, USA
    Leuk Res 26:203-6. 2002
  2. pmc Antineoplastic activity of idazoxan hydrochloride
    G F Eilon
    Long Beach, CA, USA
    Cancer Chemother Pharmacol 64:1157-63. 2009
  3. ncbi request reprint Etoposide induction of tumor immunity in Lewis lung cancer
    L M Slater
    Department of Medicine, University of California, Irvine 92697-1875, USA
    Cancer Chemother Pharmacol 48:327-32. 2001

Collaborators

  • G F Eilon
  • G Landucci
  • L Weisenthal
  • M Stupecky

Detail Information

Publications3

  1. ncbi request reprint Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16
    Lewis M Slater
    Division of Hematology Oncology, Department of Medicine, University of California Irvine, Med Surge II Room 375B, Irvine, CA 92697 1875, USA
    Leuk Res 26:203-6. 2002
    ..This impairment is associated with progressive diminution of mitogen responses by spleen cells harvested from tumor free VP-16 treated mice...
  2. pmc Antineoplastic activity of idazoxan hydrochloride
    G F Eilon
    Long Beach, CA, USA
    Cancer Chemother Pharmacol 64:1157-63. 2009
    ..It binds to mitochondrial membranes and promotes apoptosis of pancreatic beta cells. Since IDA has not been tested against tumor cells, the purpose of our study was to determine if IDA has antineoplastic activity...
  3. ncbi request reprint Etoposide induction of tumor immunity in Lewis lung cancer
    L M Slater
    Department of Medicine, University of California, Irvine 92697-1875, USA
    Cancer Chemother Pharmacol 48:327-32. 2001
    ..These findings are submitted to support the hypothesis that VP-16-induced cytotoxic changes include cellular membrane alterations in 3LL cells which are recognized by the immune system and cause rejection of this syngeneic lung tumor...